OncoBeta Commercialized Radioisotope Cancer Therapy
GmbH, during an intense discussion about the causes and repercussions of non-melanoma skin cancers. Sources have revealed that approximately five million fall ill to non-melanoma skin cancer every year and the rise in skin cancer incidence has been 300 percent since...
OncoBeta’s Rhenium-SCT® for Non-Melanoma Skin Cancer to start in South Africa
TAUTOMER / NATIVA the official Rhenium-SCT® (Skin Cancer Therapy) Distributor for Continental Africa Garching n. Munich, Germany, (June 15, 2018) – OncoBeta GmbH®, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope...
First Non-Melanocytic Skin Cancer Patients treated with Rhenium-SCT in South Africa
Garching n. Munich, Germany, (November 23, 2018) – OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), announced today that Prof. Mike Sathekge from the...